Abstract
Quality control of cell cultures used in new in vitro toxicology assays is crucial to the provision of reliable, reproducible and accurate toxicity data on new drugs or constituents of new consumer products. This chapter explores the key scientific and ethical criteria that must be addressed at the earliest stages of developing toxicology assays based on human pluripotent stem cell (hPSC) lines. It also identifies key considerations for such assays to be acceptable for regulatory, laboratory safety and commercial purposes. Also addressed is the development of hPSC-based assays for the tissue and cell types of greatest interest in drug toxicology. The chapter draws on a range of expert opinion within the European Commission/Cosmetics Europe-funded alternative testing cluster SEURAT-1 and consensus from international groups delivering this guidance such as the International Stem Cell Banking Initiative. Accordingly, the chapter summarizes the most up-date best practices in the use and quality control of human Pluripotent Stem Cell lines in the development of in vitro toxicity assays from leading experts in the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anonymous (1988) A standard nomenclature for structures of the kidney. The Renal Commission of the International Union of Physiological Sciences (IUPS). Pflugers Arch 411(1):113–120
Acimovic I, Vilotic A, Pesl M, Lacampagne A, Dvorak P, Rotrekl V, Meli AC (2014) Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed Res Int 2014:512831
Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, Manning D, Mayshar Y, McKay RD, Michalska AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O’Brien CM, Oh SK, Olsson C, Otonkoski T, Park KY, Passier R, Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RA, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz J, Turetsky T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver TA, Young LA, Zhang W, ISCI, International Stem Cell Initiative (2007) Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25:803–816
Araoka T, Mae S, Kurose Y, Uesugi M, Ohta A, Yamanaka S, Osafune K (2014) Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods. PLoS One 9(1), e84881. doi:10.1371/journal.pone.0084881
Augello A, Kurth T, De Bari C (2010) Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 20:121–133
Baharvand H, Mehrjardi NZ, Hatami M, Kiani S, Rao M, Haghighi MM (2007) Neural differentiation from human embryonic stem cells in a defined adherent culture condition. Int J Dev Biol 51(5):371–378
Barallon R, Steven R, Bauer SR, Butler J, Capes-Davis A, Dirks WG, Elmore E, Furtado M, Kline MC, Kohara A, Los GV, MacLeod RAF, Masters JRW, Nardone M, Nardone RM, Nims RW, Price PJ, Reid YA, Shewale J, Sykes G, Steuer AF, Storts DR, Thomson J, Taraporewala Z, Alston-Roberts C, Kerrigan L (2010a) Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In Vitro Cell Dev Biol Anim 46:727–732
Barallon R, Steven R, Bauer SR, Butler J, Capes-Davis A, Dirks WG, Elmore E, Furtado M, Kline MC, Kohara A, Los GV, MacLeod RAF, Masters JRW, Nardone M, Nardone RM, Nims RW, Price PJ, Reid YA, Shewale J, Sykes G, Steuer AF, Storts DR, Thomson J, Taraporewala Z, Alston-Roberts C, Kerrigan L (2010b) on behalf of ATCC® SDO Workgroup ASN-0002. Cell line misidentification: the beginning of the end. Nature Rev. Cancer 10:441–448
Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rücker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J, Mitalipov S, Gouadon E, Binder P, Hagège A, Desnos M, Renaud JF, Menasché P, Pucéat M (2010) A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120(4):1125–1139
Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24(4):349–354
Boyle S, Shioda T, Perantoni AO, de Caestecker M (2007) Cited1 and Cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis. Dev Dyn 236(8):2321–2330
Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S (2003) Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5(6):877–889
Capes-Davis A, Reid YA, Kline MC, Storts DR, Strauss E, Dirks WG, Drexler HG, MacLeod RAF, Sykes G, Kohara A, Nakamura Y, Elmore E, Nims RW, Alston-Roberts C, Barallon R, Los GV, Nardone RM, Price PJ, Steuer A, Thomson J, Masters JRW, Kerrigan L (2013) Match criteria for human cell line authentication: where do we draw the line? Intl J Cancer 132:2510–2519
Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS (2001) Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 172(2):383–397
Chen Y, Pelekanos R, Ellis R, Horne R, Wolvetang E, Fisk N (2012) Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med 1(2):83–95
Chen KT, Pernelle K, Tsai YH, Wu YH, Hsieh JY, Liao KH, Guguen-Guillouzo C, Wang HW (2014) Liver X receptor α (LXRα/NR1H3) regulates differentiation of hepatocyte-like cells via reciprocal regulation of HNF4α. J Hepatol 61(6):1276–1286
Coecke S, Balls M, Bowe G, Davis J, Gstraunthaler G, Hartung T, Hay R, Merten OW, Price A, Schechtman L, Stacey G, Stokes W (2005) Guidance on good cell culture practice. Altern Lab Anim 33:261–287
Coecke S, Bowe G, Millcamps A, Bernasconi C, Bostroem AC, Bories G, Fortaner S, Gineste JM, Gouliarmou V, Langezaal I, Liska R, Mendoza E, Morath S, Reina V, Wilk-Zasadna I, Whelan M (2014) Considerations in the development of in vitro toxicity testing methods intended for regulatory use. In: Paul J, Anna P (eds) In vitro toxicology systems, Methods in pharmacology and toxicology. Springer, New York, pp 551–569
Davies JA (2002) Morphogenesis of the metanephric kidney. ScientificWorldJournal 2:1937–1950. doi:10.1100/tsw.2002.854
Dinella J, Koster M, Koch P (2014) Use of induced pluripotent stem cells in dermatological research. J Invest Dermatol 134, e23. doi:10.1038/jid.2014.238
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317
Dressler GR (2006) The cellular basis of kidney development. Annu Rev Cell Dev Biol 22:509–529. doi:10.1146/annurev.cellbio.22.010305.104340
Dressler GR (2009) Advances in early kidney specification, development and patterning. Development 136(23):3863–3874. doi:10.1242/dev.034876
Efthymiou A, Chen G, Rao M, Chen G, Boehm M (2014) Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. Expert Opin Biol Ther 14(9):1333–1344
Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P (2007) Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 17(9):428–437
Freund C, Davis RP, Gkatzis K, Ward-van Oostwaard D, Mummery CL (2010) The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands. Neth Heart J 18(1):51–54
Genschow E, Spielmann H, Scholz G, Pohl I, Seiler A, Clemann N, Bremer S, Becker K (2004) Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 32:209–244
Gieseck IRL, Hannan NR, Bort R, Hanley NA, Drake RA, Cameron GW, Wynn TA, Vallier L (2014) Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS One 9(1), e86372
Glenn J, Whartenby K (2014) Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells 6(5):526–539
Glenner GG, Folk JE (1961) Glutamyl peptidases in rat and guinea pig kidney slices. Nature 192:338–340
Graichen R, Xu X, Braam SR, Balakrishnan T, Norfiza S, Sieh S, Soo SY, Tham SC, Mummery C, Colman A, Zweigerdt R, Davidson BP (2008) Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76(4):357–370
Green H, Easley K, Iuchi S (2003) Marker succession during the development of keratinocytes from cultured human embryonic stem cells. Proc Natl Acad Sci U S A 100:15625–15630
Guenou H, Nissan X, Larcher F, Feteira J, Lemaitre G, Saidani M, Del Rio M, Barrault CC, Bernard FX, Peschanski M et al (2009) Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis, a preclinical study. Lancet 374:1745–1753
Guo Z, Higgins C, Gillette B, Itoh M, Umegaki N, Gledhill K, Sia S, Christiano A (2013) Building a microphysiological skin model from induced pluripotent stem cells. Stem Cell Res Ther 4(Suppl 1):S2. doi:10.1186/scrt363
Gupta K, Rispin A, Stitzel K, Coecke S, Harbell J (2005) Ensuring quality of in vitro alternative test methods: issues and answers. Regul Toxicol Pharmacol 43:219–224
Han Y, Miller A, Mangada J, Liu Y, Swistowski A, Zhan M, Rao MS, Zeng X (2009) Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One 4(9), e7155. doi:10.1371/journal.pone.0007155
Haniffa M, Collin M, Buckley C, Dazzi F (2009) Mesenchymal stem cells: the fibroblasts’ new clothes? Haematologica 94(2):258–263
Harrill JA, Freudenrich TM, Machacek DW, Stice SL, Mundy WR (2010) Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis. Neurotoxicology 31(3):277–290
Hartung T, Gstraunthaler G, Balls M (2000) Bologna statement on good cell culture practice (GCCP). ALTEX 17:38–39
Hay DC, Fletcher J, Payne C, Terrace JD, Gallagher RC, Snoeys J, Black JR, Wojtacha D, Samuel K, Hannoun Z, Pryde A, Filippi C, Currie IS, Forbes SJ, Ross JA, Newsome PN, Iredale JP (2008) Highly efficient differentiation of hESCs to functional hepatic endoderm requires Activin A and Wnt3a signaling. Proc Natl Acad Sci U S A 105(34):12301–12306
Hematti P (2011) Human embryonic stem cell-derived mesenchymal progenitors: an overview. Methods Mol Biol 690:163–174
Hematti P (2012) Mesenchymal stromal cells and fibroblasts: a case of mistaken identity? Cytotherapy 14(5):516–521
Hogberg HT, Sobanski T, Novellino A, Whelan M, Weiss DG, Bal-Price AK (2011) Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat cortical neurons. Neurotoxicology 32(1):158–168
Holthofer H, Ahola H, Solin ML, Wang S, Palmen T, Luimula P, Miettinen A, Kerjaschki D (1999) Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol 155(5):1681–1687
Holzman LB, St John PL, Kovari IA, Verma R, Holthofer H, Abrahamson DR (1999) Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int 56(4):1481–1491
Horvat R, Hovorka A, Dekan G, Poczewski H, Kerjaschki D (1986) Endothelial cell membranes contain podocalyxin—the major sialoprotein of visceral glomerular epithelial cells. J Cell Biol 102(2):484–491
International Stem Cell Banking Initiative, Andrews PW, Arias-Diaz J, Auerbach J et al (2009) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev 5:301–314
Isasi R, Andrews PW, Baltz JM, Bredenoord AL, Burton P, Chiu IM, Hull SC, Jung JW, Kurtz A, Lomax G, Ludwig T, McDonald M, Morris C, Ng HH, Rooke H, Sharma A, Stacey GN, Williams C, Zeng F, Knoppers BM (2014) Identifiability and privacy in pluripotent stem cell research. Cell Stem Cell 14(4):427–430
Islam M, Stemig M, Takahashi Y, Hui S (2015) Radiation response of mesenchymal stem cells derived from bone marrow and human pluripotent stem cells. J Radiat Res 56(2):269–277
Itoh M, Kiuru M, Cairo MS, Christiano AM (2011) Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci U S A 108:8797–8802
Ivashchenko CY, Pipes GC, Lozinskaya IM, Lin Z, Xiaoping X, Needle S, Grygielko ET, Hu E, Toomey JR, Lepore JJ, Willette RN (2013) Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am J Physiol Heart Circ Physiol 305(6):H913–H922
Jennings P, Koppelstaetter C, Helbert MJ, Pfaller W (2003) Renal culture models: Contribution to the understanding of nephrotoxic mechanisms. Clinical Nephrotoxins: Renal Injury from drugs and chemicals, 2nd edn, pp. 115–147
Jennings P, Koppelstaetter C, Lechner J, Pfaller W (2008) Renal culture models: contribution to the understanding of nephrotoxic mechanisms. In: Broe ME, Porter GA (eds) Clinical nephrotoxins: renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 223–250
Jennings P, Aschauer L, Wilmes A, Gstraunthaler G (2014) Renal cell culture. In: Jennings P, Bal-Price A (eds) In vitro toxicology systems. Methods in pharmacology and toxicology. Springer, New York, pp 79–101. doi:10.1007/978-1-4939-0521-8_4
Kerjaschki D, Sharkey DJ, Farquhar MG (1984) Identification and characterization of podocalyxin—the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98(4):1591–1596
Kerrigan L, Nims RW (2011) Authentication of human cell-based products: the role of a new consensus standard. Regen Med 6:255–260, http://standards.atcc.org/kwspub/home/the_international_cell_line_authentication_committee-iclac_/)
Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1(4):575–582
Knoppers BM, Isasi R, Benvenisty N, Kim OJ, Lomax G, Morris C, Murray TH, Lee EH, Perry M, Richardson G, Sipp D, Tanner K, Wahlström J, de Wert G, Zeng F (2011) Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party. Stem Cell Rev 7(3):482–484
Kriz W, Kaissling B (2000) Structural organization of the mammalian kidney, vol 1, 3rd edn, The kidney, physiology and pathophysiology. Lippincott Williams & Wilkins, Philadelphia
Lam AQ, Freedman BS, Morizane R, Lerou PH, Valerius MT, Bonventre JV (2014) Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol 25(6):1211–1225
Lappalainen RS, Salomäki M, Ylä-Outinen L, Heikkilä TJ, Hyttinen JA, Pihlajamäki H, Suuronen R, Skottman H, Narkilahti S (2010) Similarly derived and cultured hESC lines show variation in their developmental potential towards neuronal cells in long-term culture. Regen Med 5(5):749–762
Laustriat D, Gide J, Peschanski M (2010) Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem Soc Trans 38:1051–1057
Lee YK, Ng KM, Lai WH, Chan YC, Lau YM, Lian Q, Tse HF, Siu CW (2011) Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev 7(4):976–986
Li C, Ruotsalainen V, Tryggvason K, Shaw AS, Miner JH (2000) CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere. Am J Physiol Renal Physiol 279(4):F785–F792
Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S (2013) Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies. PLoS One 8(1), e55319. doi:10.1371/journal.pone.0055319
Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, Palecek SP (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 109(27):E1848–E1857
Lim SY, Sivakumaran P, Crombie DE, Dusting GJ, Pébay A, Dilley RJ (2013) Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering. Stem Cells Transl Med 2(9):715–725
Lundy SD, Zhu WZ, Regnier M, Laflamme MA (2013) Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 22(14):1991–2002
Luong MX, Auerbach J, Crook JM, Daheron L, Hei D, Lomax G, Loring JF, Ludwig T, Schlaeger TM, Smith KP, Stacey G, Xu RH, Zeng F (2011) A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell 8(4):357–359
Luong MXL, Smith KP, Crook JM, Stacey GN (2012) Biobanks for pluripotent stem cells (Chapter 8). In: Loring JF, Petersen SE (eds) Human stem cell manual, 2nd edn. Elsevier, London, pp 105–125
MacLeod RAF, Dirks WG, Matsuo Y, Kaufman M, Milch H, Drexler HG (1999) Widespread intra-species cross-contamination of human tumour cell lines arising at source. Int J Cancer 83:555–563
Mordwinkin NM, Burridge PW, Wu JC (2013) A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. J Cardiovasc Transl Res 6(1):22–30
Motohashi H, Nakao Y, Masuda S, Katsura T, Kamba T, Ogawa O, Inui K (2013) Precise comparison of protein localization among OCT, OAT, and MATE in human kidney. J Pharm Sci 102(9):3302–3308
Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L (2003) Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107(21):2733–2740
Muto S, Hata M, Taniguchi J, Tsuruoka S, Moriwaki K, Saitou M, Furuse K, Sasaki H, Fujimura A, Imai M, Kusano E, Tsukita S, Furuse M (2010) Claudin-2-deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules. Proc Natl Acad Sci U S A 107(17):8011–8016
Narayanan K, Schumacher KM, Tasnim F, Kandasamy K, Schumacher A, Ni M, Gao S, Gopalan B, Zink D, Ying JY (2013) Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney Int 83(4):593–603
Nat R, Nilbratt M, Narkilahti S, Winblad B, Hovatta O, Nordberg A (2007) Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia 55(4):385–399
Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA (2002) Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82(1):205–244
Nims RW, Sykes G, Cottrill K, Ikonomi P, Elmore E (2010) Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification. In Vitro Cell Dev Biol Anim 46:811–819
Novellino A, Scelfo B, Palosaari T, Price A, Sobanski T, Shafer TJ, Johnstone AF, Gross GW, Gramowski A, Schroeder O, Jügelt K, Chiappalone M, Benfenati F, Martinoia S, Tedesco MT, Defranchi E, D’Angelo P, Whelan M (2011) Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals. Front Neuroeng 4:4. doi:10.3389/fneng.2011.00004
Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B, Jiang J, Massé S, Gagliardi M, Hsieh A, Thavandiran N, Laflamme MA, Nanthakumar K, Gross GJ, Backx PH, Keller G, Radisic M (2013) Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 10(8):781–787
OECD (2005) OECD series on testing and assessment. Number 34. Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment. ENV/JM/MONO(2005)14
Paige SL, Osugi T, Afanasiev OK, Pabon L, Reinecke H, Murry CE (2010) Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 5(6), e11134
Pan GJ, Chang ZY, Scholer HR, Pei D (2002) Stem cell pluripotency and transcription factor Oct4. Cell Res 12(5–6):321–329
Passier R, Oostwaard DW, Snapper J, Kloots J, Hassink RJ, Kuijk E, Roelen B, de la Riviere AB, Mummery C (2005) Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23(6):772–780
Petrova A, Celli A, Jacquet L, Dafou D, Crumrine D, Hupe M, Arno M, Hobbs C, Cvoro A, Karagiannis P, Devito L, Sun R, Adame L, Vaughan R, McGrath J, Mauro T, Ilic D (2014) 3D in vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells. Stem Cell Reports 2(5):675–689
Pistollato F, Bremer-Hoffmann S, Healy L, Young L, Stacey G (2012) Standardization of pluripotent stem cell cultures for toxicity testing. Expert Opin Drug Metab Toxicol 8:239–257
Ren Y, Lee MY, Schliffke S, Paavola J, Amos PJ, Ge X, Ye M, Zhu S, Senyei G, Lum L, Ehrlich BE, Qyang Y (2011) Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J Mol Cell Cardiol 51(3):280–287
Richert L, Liguori MJ, Abadie C, Heyd B, Mantion G, Halkic N, Waring JF (2006) Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating. Drug Metab Dispos 34(5):870–879
Rispin A, Harbell JW, Klausner M, Jordan FT, Coecke S, Gupta K, Stitzek K (2004) Quality assurance for in vitro alternative test methods: quality control issues in test kit production. Altern Lab Anim 1(Suppl):725–729
Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attie T, Gubler MC, Antignac C (2002) Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160(1):131–139
Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestila M, Jalanko H, Holmberg C, Tryggvason K (1999) Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A 96(14):7962–7967
Sariola H (2002) Nephron induction. Nephrol Dial Transplant 17(Suppl 9):88–90
Scanu M, Mancuso L, Cao G (2011) Evaluation of the use of human Mesenchymal Stem Cells for acute toxicity tests. Toxicol In Vitro 25(8):1989–1995
Schulz TC, Noggle SA, Palmarini GM, Weiler DA, Lyons IG, Pensa KA, Meedeniya AC, Davidson BP, Lambert NA, Condie BG (2004) Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22(7):1218–1238
Schwartz RE, Fleming HE, Khetani SR, Bhatia SN (2014) Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv 32(2):504–513
Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P (2001) Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108(11):1621–1629
Scott CW, Peters MF, Dragan YP (2013) Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. Toxicol Lett 219(1):49–58
Shan J, Schwartz RE, Ross NT, Logan DJ, Thomas D, Duncan SA, North TE, Goessling W, Carpenter AE, Bhatia SN (2013) Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol 9(8):514–520
Shih NY, Li J, Cotran R, Mundel P, Miner JH, Shaw AS (2001) CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 159(6):2303–2308. doi:10.1016/S0002-9440(10)63080-5
Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I, Smith A (2009) Nanog is the gateway to the pluripotent ground state. Cell 138(4):722–737
Sirenko O, Hesley J, Rusyn I, Cromwell EF (2014) High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Assay Drug Dev Technol 12(1):43–54
Sivertsson L, Synnergren J, Jensen J, Björquist P, Ingelman-Sundberg M (2013) Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor. Stem Cells Dev 22(4):581–594
Soleimani M (2015) The multiple roles of pendrin in the kidney. Nephrol Dial Transplant 30(8):1257–1266. doi:10.1093/ndt/gfu307
Song B, Smink AM, Jones CV, Callaghan JM, Firth SD, Bernard CA, Laslett AL, Kerr PG, Ricardo SD (2012) The directed differentiation of human iPS cells into kidney podocytes. PLoS One 7(9), e46453. doi:10.1371/journal.pone.0046453
Stacey G, Day JG (2007) Long-term ex situ conservation of biological resources and the role of biological resource centers. In: Day DG, Stacey GN (eds) Cryopreservation and freezedrying methods. Humana Press, Totowa
Stacey GN, Masters JR (2008) Cryopreservation and banking of mammalian cell lines. Nat Protoc 3:1981–1989
Stacey G, Masters JRW, Hay RJ, Drexler HG, MacLeod RAF, Freshney IR (2000) Cell contamination leads to inaccurate data: we must take action now. Nature 403:356
Stacey G, Pistollato F, Healy L, Bremer S, Young L, Strehl R, Hyllner J, Emmanuelsson K and Peschanski M on behalf of the Scr&Tox and ToxBank consortia (2012) General Quality and Regulatory Criteria for Establishment and Dissemination of human Pluripotent Stem Cell Lines (hPSCs). Poster presented at Surat-1 scientific meeting Lisbon, 2012 and published on the ToxBank data warehouse at http://www.toxbank.net/bio-wiki or http://wiki.toxbank.net/w/images/0/08/ToxBank_poster5-CellStandards-120130.pdf
Stacey G, Healy L, Kidane L (2012) Points to consider in gaining access to human tissue and cell lines. ToxBank Deliverable 4.6. http://wiki.toxbank.net/w/images/1/18/ToxBank_D4_6_final_10_04_13.pdf
Stacey G, Kidane L, Healy L, Myatt G on behalf of ToxBank consortium (2014) Deliverable D4.7. Inventory and map of European suppliers: materials, resources, facilities and standards. http://wiki.toxbank.net/w/images/c/c2/ToxBank_D4_7_Final_11.06.13.pdf
Stacey G, Kidane L, Healy L, Myatt G, Hardy B, Bremer S (2014) Coordination of data systems in SEURAT-1 and alternative testing regulatory frameworks to provide smooth and efficient translation of research developments to qualified toxicity assays. Poster presented at SEURAT-1 scientific meeting Lisbon, 2014 and published on the ToxBank data warehouse at http://www.toxbank.net/bio-wiki; http://wiki.toxbank.net/w/images/3/35/ToxBank_ToxBank_JRC_Coord_Poster_Stacey_et_al.pdf
Stanley EG, Biben C, Elefanty A, Barnett L, Koentgen F, Robb L, Harvey RP (2002) Efficient Cre-mediated deletion in cardiac progenitor cells conferred by a 3′UTR-ires-Cre allele of the homeobox gene Nkx2-5. Int J Dev Biol 46(4):431–439
Subramanian K, Owens DJ, Raju R, Firpo M, O’Brien TD, Verfaillie CM, Hu WS (2014) Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells. Stem Cells Dev 23(2):124–131
Sutton M, Bonfield T (2014) Stem cells: innovations in clinical applications. Stem Cells Int 2014:516278. doi:10.1155/2014/516278
Szkolnicka D, Farnworth SL, Lucendo-Villarin B, Storck C, Zhou W, Iredale JP, Flint O, Hay DC (2014) Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med 3(2):141–148
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
Takasato M, Er PX, Becroft M, Vanslambrouck JM, Stanley EG, Elefanty AG, Little MH (2014) Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell Biol 16(1):118–126
Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, Aoyama S, Adachi Y, Taniguchi H (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499(7459):481–484
Takebe T, Zhang RR, Koike H, Kimura M, Yoshizawa E, Enomura M, Koike N, Sekine K, Taniguchi H (2014) Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc 9(2):396–409
Tang M, Chen W, Liu J, Weir M, Cheng L, Xu H (2014) Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Eng Part A 20(7–8):1295–1305
Tarunina M, Hernandez D, Johnson CJ, Ramathas V, Jeyakumar M, Watson T et al (2014) Directed differentiation of embryonic stem cells using a bead-based combinatorial screening method. PLoS ONE 9(9), e104301. doi:10.1371/journal.pone.0104301
TheinHan W, Liu J, Tang M, Chen W, Cheng L, Xu H (2013) Induced pluripotent stem cell-derived mesenchymal stem cell seeding on biofunctionalized calcium phosphate cements. Bone Res 4:371–384
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Ulvestad M, Nordell P, Asplund A, Rehnström M, Jacobsson S, Holmgren G, Davidson L, Brolén G, Edsbagge J, Björquist P, Küppers-Munther B, Andersson TB (2013) Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells. Biochem Pharmacol 86(5):691–702
United States Pharmacoipoiea (2013) General Chapter. Cryopreservation of Cells, U.S. Pharmacopeia and the National Formulary (USP–NF). http://www.usp.org/council-experts-expert-committees-overview/expert-committees/general-chapters-biological-analysis
Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, Yamanaka S, Yamashita JK (2011) Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One 6(8), e23657
Van Itallie CM, Rogan S, Yu A, Vidal LS, Holmes J, Anderson JM (2006) Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am J Physiol Renal Physiol 291(6):F1288–F1299
Vinoth K, Manikandan J, Sethu S, Balakrishnan L, Heng A, Lu K, Hande M, Cao T (2014) Evaluation of human embryonic stem cells and their differentiated fibroblastic progenies as cellular models for in vitro genotoxicity screening. J Biotechnol 184:154–168
Wilmes A, Jennings P (2014) The use of renal cell culture for nephrotoxicity investigations. In: Predictive toxicology. Wiley-VCH Verlag GmbH & Co, KGaA, Weinheim, pp 195–216. doi:10.1002/9783527674183.ch10
Wilmes A, Aschauer L, Limonciel A, Pfaller W, Jennings P (2014) Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol Appl Pharmacol 279(2):163–172
Xia Y, Nivet E, Sancho-Martinez I, Gallegos T, Suzuki K, Okamura D, Wu MZ, Dubova I, Esteban CR, Montserrat N, Campistol JM, Izpisua Belmonte JC (2013) Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat Cell Biol 15(12):1507–1515. doi:10.1038/ncb2872
Yuan SH, Martin J, Elia J, Flippin J, Paramban RI, Hefferan MP, Vidal JG, Mu Y, Killian RL, Israel MA, Emre N, Marsala S, Marsala M, Gage FH, Goldstein LS, Carson CT (2011) Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 6(3), e17540. doi:10.1371/journal.pone.0017540
Zeng X, Chen J, Deng X, Liu Y, Rao MS, Cadet JL, Freed WJ (2006) An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF neuroprotection. Neuropsychopharmacology 31(12):2708–2715
Zeng H, Guo M, Martins-Taylor K, Wang X, Zhang Z, Park JW, Zhan S, Kronenberg MS, Lichtler A, Liu HX, Chen FP, Yue L, Li XJ, Xu RH (2010) Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One 5(7), e11853. doi:10.1371/journal.pone.0011853
Zhang SC, Wernig M, Duncan ID, Brüstle O, Thomson JA (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19(12):1129–1133
Zhang P, Li J, Tan Z, Wang C, Liu T, Chen L, Yong J, Jiang W, Sun X, Du L, Ding M, Deng H (2008) Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 111(4):1933–1941
Zhou J, Su P, Li D, Tsang S, Duan E, Wang F (2010) High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 28(10):1741–1750
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix 1: Ethics Criteria for Cell Lines Selection (hiPSCs and hESCs)
Appendix 1: Ethics Criteria for Cell Lines Selection (hiPSCs and hESCs)
In order to establish that all cell lines were obtained from tissue that has been ethically sourced the researchers must be able to provide evidence for the following:
-
That fully informed consent was obtained and recorded for the donor tissue
-
That consent permits the intended uses of the hPSC lines derived from the donor’s tissue
-
That the donor’s identity was anonymised
-
A validated copy of the original consent form (with donor details redacted) is available and/or a statement is available from a person authorised by the owner or derivation centre on the ethical provenance of the cell line including a contact that would facilitate confirmation of the original consent without breaking donor anonymity.
-
There should be a clear statement on any constraints applied by the donor on the use of derivatives from their cells/tissues.
-
Cell lines are registered within the hESCreg database
-
Copies of blank consent form (or an English translation) and any information provided to the donor are available.
-
Evidence from the donation process that the donor was aware that:
-
Derived lines may be exploited commercially but that donors would not receive personal financial benefit.
-
The donors decision to donate tissue would not influence their personal treatment an there would be no feedback on data from the cell line derived from their tissue. Derived hPSCs could be used for a wide range of purposes in different laboratories and may be tested for genetic characteristics, microbiological contamination and other features of the cells.
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Stacey, G.N. et al. (2016). Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing. In: Eskes, C., Whelan, M. (eds) Validation of Alternative Methods for Toxicity Testing. Advances in Experimental Medicine and Biology, vol 856. Springer, Cham. https://doi.org/10.1007/978-3-319-33826-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-33826-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33824-8
Online ISBN: 978-3-319-33826-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)